CIK 0001725160 · Non-accelerated filer<br>Smaller reporting company
Zentalis Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ZNTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 823607803
- Phone
- (858) 263-4333
- Business address
- 10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-03 | Bruns Ingmar Chief Medical Officer | Grant or award | +16,629 | 16,629 | ||
| 2025-02-03 | Bruns Ingmar Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +16,629 | 16,629 | ||
| 2025-02-03 | EASTLAND JULIA MARIE CEO & President | Grant or award | +59,388 | 87,888 | ||
| 2025-02-03 | EASTLAND JULIA MARIE CEO & President | Grant or award · Stock Option (Right to Buy) | +59,388 | 59,388 | ||
| 2025-01-31 | Skvarka Jan Director | Purchase | +60,000 | $1.72 | $103K | 149,551 |
| 2025-01-31 | Walker Luke Nathaniel Director | Purchase | +14,200 | $1.76 | $25K | 86,681 |
| 2025-01-31 | EASTLAND JULIA MARIE CEO & President | Purchase | +28,500 | $1.73 | $49K | 28,500 |
| 2025-01-02 | Lackner Mark Chief Scientific Officer | Sale | −4,411 | $3.12 | $14K | 191,317 |
| 2024-12-02 | Bruns Ingmar Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +712,650 | 712,650 | ||
| 2024-12-02 | EASTLAND JULIA MARIE CEO & President | Grant or award · Stock Option (Right to Buy) | +3,028,800 | 3,028,800 | ||
| 2024-11-13 | Myers Scott Dunseth Director | Grant or award | +260,192 | 260,192 | ||
| 2024-10-04 | Vultaggio Vincent Principal Accounting Officer | Sale 10b5-1 | −1,603 | $3.18 | $5K | 33,855 |
| 2024-06-21 | Skvarka Jan Director | Grant or award | +41,581 | 89,551 | ||
| 2024-06-21 | Kariuki Enoch Director | Grant or award | +41,581 | 79,762 | ||
| 2024-06-21 | Johnson David Michael Director | Grant or award | +48,429 | 192,818 | ||
| 2024-05-31 | Gallagher Cam President, Interim CFO | Sale | −9,597 | $11.98 | $115K | 633,680 |
| 2024-05-24 | Walker Luke Nathaniel Director | Grant or award | +72,481 | 72,481 | ||
| 2024-05-09 | HAUSMAN DIANA Chief Medical Officer | Sale | −3,356 | $12.62 | $42K | 373,876 |
| 2024-02-12 | Epperly Melissa B, Chief Financial Officer | Sale | −2,573 | $11.44 | $29K | 451,449 |
| 2024-02-12 | Gallagher Cam President | Sale | −1,173 | $11.44 | $13K | 643,277 |
Page 3 of 8 · 160 trades